Kexrolt

Atorvastatin and Ezetimibe, the active ingredients in Kexrolt, are HMG‑CoA reductase inhibitor and cholesterol absorption inhibitor presented as an oral tablet for adult use. They lower elevated LDL‑cholesterol and total cholesterol in patients with hypercholesterolemia or mixed dyslipidemia.

GNH USA supplies Kexrolt as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Kexrolt acts on lipid metabolism to treat several cholesterol‑related disorders. Hypercholesterolemia: reduces LDL‑cholesterol and total cholesterol levels. Mixed dyslipidemia: lowers triglycerides and improves the overall lipid profile. Heterozygous familial hypercholesterolemia: helps patients achieve target LDL‑cholesterol when diet and lifestyle are insufficient.

Kexrolt may cause a range of adverse reactions.

Common Side Effects: - Headache: mild to moderate intensity. - Myalgia: muscle aches without weakness. - Gastrointestinal discomfort: nausea, abdominal pain or diarrhoea. - Elevated liver enzymes: mild transaminase increases. - Fatigue: general tiredness. - Dizziness: occasional light‑headedness.

Serious or Rare Side Effects: - Rhabdomyolysis: severe muscle breakdown with dark urine. - Acute liver injury: marked elevation of hepatic enzymes or jaundice. - Severe allergic reaction: rash, swelling, or anaphylaxis. - Hepatotoxicity: liver failure in rare cases. - Myopathy with weakness: persistent muscle weakness. - Renal impairment: secondary to muscle breakdown.

Before starting Kexrolt, consider the following safety measures. Monitor liver function: obtain baseline transaminases and repeat periodically. Assess muscle symptoms: discontinue if severe myalgia, weakness or dark urine develop. Avoid in active liver disease: contraindicated in patients with ongoing hepatic impairment. Use caution with CYP3A4 inhibitors: dose adjustment may be required. Pregnancy: not recommended unless benefits outweigh potential risks. Store at room temperature: keep in original packaging, protect from moisture and light.

Kexrolt can interact with several medicines; awareness helps prevent adverse events.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., clarithromycin, itraconazole): increase atorvastatin exposure. - Gemfibrozil: heightened risk of myopathy and rhabdomyolysis. - Cyclosporine: may raise plasma concentrations of both components. - Niacin (high dose): additive risk of muscle toxicity. - Certain antifungals (e.g., ketoconazole): potentiate statin levels.

Moderate Interactions (Monitor Closely): - Warfarin: may enhance anticoagulant effect, monitor INR. - Digoxin: slight increase in serum levels. - Antacids containing aluminum or magnesium: may reduce ezetimibe absorption. - Beta‑blockers: monitor for additive lipid‑lowering effect. - Fibrates (low dose): watch for muscle-related side effects.